BeingWell
Published in

BeingWell

Coronavirus Vaccine Goes Into Phase 1 Trial

The first patients in Seattle, WA have been injected with a novel vaccine aimed at curbing COVID-19 infections in humans. The vaccine was introduced to a cohort of patients yesterday in hopes that it will trigger immunity to the rapidly developing virus.

Volunteers between 18 and 55 years old at the Kaiser Permanente Washington Health Research Institute were given the first of two doses…

--

--

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Jesse Smith, MS

Jesse Smith, MS

3.6K Followers

Medical student and molecular biologist. I write about science, medicine, vaccines and dogs…yes dogs.